"Mammaglobin A" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A secretoglobin that is produced by the MAMMARY GLAND of HUMANS and may be involved in the binding of ANDROGENS and other STEROIDS. The expression of this protein in normal breast epithelium and in human breast cancer has made it an important histological marker.
Descriptor ID |
D060785
|
MeSH Number(s) |
D12.776.861.249 D23.101.140.425
|
Concept/Terms |
Mammaglobin A- Mammaglobin A
- Secretoglobin Family 2A Member 2
- Mammaglobin 1
- Mammaglobin-A
|
Below are MeSH descriptors whose meaning is more general than "Mammaglobin A".
Below are MeSH descriptors whose meaning is more specific than "Mammaglobin A".
This graph shows the total number of publications written about "Mammaglobin A" by people in this website by year, and whether "Mammaglobin A" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 0 | 1 | 1 |
2012 | 1 | 0 | 1 |
2014 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mammaglobin A" by people in Profiles.
-
Immunohistochemical Markers for Distinguishing Metastatic Breast Carcinoma from Other Common Malignancies: Update and Revisit. Semin Diagn Pathol. 2022 Sep; 39(5):313-321.
-
GATA-binding protein 3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast cancer by immunohistochemistry. Histopathology. 2015 Aug; 67(2):245-54.
-
Safety and preliminary evidence of biologic efficacy of a mammaglobin-a DNA vaccine in patients with stable metastatic breast cancer. Clin Cancer Res. 2014 Dec 01; 20(23):5964-75.
-
Immunohistochemical evaluation of GATA-3 expression in ER-negative breast carcinomas. Am J Clin Pathol. 2014 May; 141(5):648-55.
-
Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer. Histopathology. 2013 Jan; 62(2):267-74.
-
Mammaglobin A, a novel marker of minimal residual disease in early stages breast cancer. Neoplasma. 2004; 51(3):204-8.